Cyclosporin A Eye Drop Treatment in Vernal Keratoconjunctivitis

PHASE3CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

February 28, 2007

Primary Completion Date

October 31, 2008

Study Completion Date

October 31, 2008

Conditions
Vernal Keratoconjunctivitis
Interventions
DRUG

Cyclosporine A 0,05% eye drop

Cyclosporine A 0.05% eye drops will be administered 2 times daily for six months in the first year of the study and in the second year of the study in a cross-over manner(from March to September)

DRUG

ketotifen fumarate 0.025% eye drops

ketotifen fumarate 0.025% eye drops 2 times daily for 6 months in the first year of the study (from March to September) and 6 months in the same period in the second year of the study in cross over manner.

Trial Locations (3)

00155

University of Rome Campus Bio-Medico, Rome

Unknown

University of Genova, Genova

University of Padua, Padua

All Listed Sponsors
collaborator

University of Genova

OTHER

collaborator

University of Padova

OTHER

lead

Campus Bio-Medico University

OTHER

NCT00426023 - Cyclosporin A Eye Drop Treatment in Vernal Keratoconjunctivitis | Biotech Hunter | Biotech Hunter